Rapid Novor Inc

Some binders never get a second chance.

Early antibody selection decisions determine which candidates move forward and which are left behind, but not all screening methods give you all the information you need to make the best decision moving forward.

Our SPR Kinetic Screening using the Biacore 1K is designed to uncover the interactions that less sensitive approaches can miss.

Because the best hit might have been the one that was left behind.

Technology has come a long way, but some things never change… 😅

What's one thing that would improve your life in the lab?

We’re counting down to and excited to be part of this year’s event!

📍Stop by Booth 318 anytime next week (May 11–15) to connect with Mingjie Xie, Thierry le Bihan, Jennifer Crha, and Kyle Annibale.

Catch Thierry’s presentation on anti-idiotype antibodies on Tuesday and the corresponding poster on Thursday!

𝘊𝘰𝘯𝘷𝘦𝘳𝘴𝘪𝘰𝘯 𝘰𝘧 𝘗𝘰𝘭𝘺𝘤𝘭𝘰𝘯𝘢𝘭 𝘈𝘯𝘵𝘪-𝘐𝘥𝘪𝘰𝘵𝘺𝘱𝘦𝘴 𝘪𝘯𝘵𝘰 𝘊𝘩𝘢𝘳𝘢𝘤𝘵𝘦𝘳𝘪𝘻𝘦𝘥 𝘙𝘦𝘤𝘰𝘮𝘣𝘪𝘯𝘢𝘯𝘵 𝘈𝘯𝘵𝘪𝘣𝘰𝘥𝘪𝘦𝘴:

💬𝗣𝗼𝗱𝗶𝘂𝗺 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 - Track C2A
Tuesday May 12, 12:15 PM

📊 𝗣𝗼𝘀𝘁𝗲𝗿 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 – Poster C091
Thursday May 15 (all day)

We’re looking forward to sharing how our REpAb platform is advancing polyclonal antibody discovery—enabling the conversion of complex mixtures into well-defined recombinant reagents.

See you there!